Humans who have been exposed to Beta-methylamino-L-alanine (L- BMAA) developed amyotrophic lateral sclerosis Parkinson-dementia complex, (ALS-PDC). The structure of L-BMAA is similar to glutamate, making it a glutamate agonist. Since glutamate is an e . . .